GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | CDK1 | affects expression | EXP | | 6480464 | CTD | Arsenic Trioxide affects the expression of CDK1 mRNA | PMID:18088464 | CDK1 | decreases activity | EXP | | 6480464 | CTD | Arsenic Trioxide results in decreased activity of CDK1 protein | PMID:10850458 | CDK1 | decreases expression | EXP | | 6480464 | CTD | Arsenic Trioxide results in decreased expression of CDK1 protein modified form | PMID:19825857 | CDK1 | increases expression | EXP | | 6480464 | CTD | Arsenic Trioxide results in increased expression of CDK1 mRNA | PMID:20862710 | CDK1 | multiple interactions | EXP | | 6480464 | CTD | [Arsenic Trioxide co-treated with Paclitaxel] results in increased activity of CDK1 protein; [Arsenic Trioxide co-treated with Paclitaxel] results in increased expression of CDK1 protein modified form; Arsenic Trioxide promotes the reaction [CDK1 protein binds to CDKN1A protein]; Arsenic Trioxide results in decreased expression of and results in increased phosphorylation of CDK1 protein; PTEN protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of CDK1 protein] | PMID:10850458 PMID:19781537 PMID:22730174 | CDK1 | multiple interactions | ISO | Cdk1 (Rattus norvegicus) | 6480464 | CTD | Arsenic Trioxide results in increased expression of and results in increased phosphorylation of CDK1 protein | PMID:23337567 | |
Go Back to source page | Continue to Ontology report |